Shane T. Grosser

Merck & Co., Inc., Rahway, NJ, USA (United States)

Papers

1

Total Citations

2

H-Index

1

About

Shane T. Grosser is a leading figure in the automation of chemical synthesis, with a primary focus on accelerating reaction optimization through high-throughput experimentation and advanced analytical integration. His most notable contribution is the development of **RAVE MS (Robotically Automated Vacuum Enabled Direct-Inject Mass Spectrometry)**, a groundbreaking platform that leverages low-cost mass spectrometer and autosampler hardware to achieve a remarkable sampling rate of approximately 12 seconds per sample. This innovation dramatically reduces the time required for reaction screening, delivering results comparable to commercial direct-inject systems at a fraction of the cost. Grosser's work bridges the gap between robotics and real-time analytics, enabling chemists to iterate and optimize reactions with unprecedented speed. His research has already garnered attention in the field, with his 2025 paper on RAVE MS accumulating 2 citations in its early release. By democratizing access to high-speed reaction analysis, Grosser is poised to transform how laboratories approach cross-modality optimization, making him a pivotal contributor to the future of automated chemical discovery.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Accelerating cross-modality reaction optimization <i>via</i> robotically automated vacuum enabled direct-inject mass spectrometry (RAVE MS)
2 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago